Technology
Equinix Reports Fourth-Quarter and Full-Year 2023 Results
Published
3 years agoon
By
REDWOOD CITY, Calif., Feb. 14, 2024 /PRNewswire/ —
2023 annual revenues increased 13% year-over-year on an as-reported basis and 15% on a normalized and constant currency basis to $8.2 billionClosed nearly 17,000 deals across more than 5,900 customers in 2023Record 90 megawatts (“MW”) of xScale® leasing, the result of increased hyperscale demand to support artificial intelligence (AI) and cloud deployments
Equinix, Inc. (Nasdaq: EQIX), the world’s digital infrastructure company®, today reported results for the quarter and year ended December 31, 2023. Equinix uses certain non-GAAP financial measures, which are described further below and reconciled to the most comparable GAAP financial measures after the presentation of our GAAP financial statements. All per-share results are presented on a fully diluted basis.
2023 Results Summary
Revenues $8.188 billion, a 13% increase over the previous year on an as-reported basis or 15% on a normalized and constant currency basisOperating Income$1.443 billion, a 20% increase over the previous year, and an operating margin of 18% due to strong operating performanceNet Income and Net Income per Share attributable to common shareholders $969 million, a 38% increase over the previous year, primarily due to operating performance strength and other income; partially offset by higher income taxes$10.31 per share, a 34% increase over the previous yearAdjusted EBITDA$3.702 billion, a 45% adjusted EBITDA margin, an increase of 10% compared to last year on an as-reported basisIncludes $13 million of integration costsAFFO and AFFO per Share$3.019 billion, an 11% increase over the previous year on an as-reported basis or 13% on a normalized and constant currency basis$32.11 per share, a 9% increase over the previous year on an as-reported basis or 11% on a normalized and constant currency basis
2024 Annual Guidance Summary
Revenues$8.793 – $8.893 billion, a 7 – 9% increase over the previous year on an as-reported basis or a normalized and constant currency increase of 7 – 8% excluding the year-over-year impact of the power pass-throughAdjusted EBITDA$4.089 – $4.169 billion, a 47% adjusted EBITDA margin, a 10 – 13% increase over the prior year on an as-reported basisAssumes $25 million of integration costsAFFO and AFFO per Share$3.306 – $3.376 billion, an increase of 9 – 12% over the previous year on both an as-reported and normalized and constant currency basis$34.58 – $35.31 per share, an increase of 8 – 10% over the previous year on both an as-reported and normalized and constant currency basisThis guidance excludes any capital market activities the company may undertake in the future
Equinix does not provide forward-looking guidance for certain financial data, such as depreciation, amortization, accretion, stock-based compensation, net income (loss) from operations, cash generated from operating activities and cash used in investing activities, and as a result, is not able to provide a reconciliation of GAAP to non-GAAP financial measures for forward-looking data without unreasonable effort. The impact of such adjustments could be significant.
Equinix Quote
Charles Meyers, CEO and President, Equinix:
“2023 was another strong year for Equinix—we delivered more than $8 billion of revenues, achieving an amazing 21 years of consecutive quarterly revenue growth, all while driving AFFO per share performance above the top end of our long-term expectations. We made substantial progress on our ambitious agenda, positioning the business to capitalize on the immense opportunities that lie ahead. Digital transformation, especially in an AI-driven world, is as important as ever to our customers. In this context, the significance of Platform Equinix and its strong competitive advantages has never been more crucial. We plan to continue our focus on creating a platform that allows our customers to build hybrid and multicloud infrastructure, when they want, where they want, and with the ecosystem of partners they need.”
Business Highlights
Given the strong underlying demand for digital infrastructure, Equinix continues to invest broadly across its global footprint, which now includes 260 data centers across 71 metropolitan areas in 33 countries. There are 49 major builds underway in 35 markets, across 21 countries including 11 xScale builds representing nearly 20,000 cabinets of retail and more than 50 megawatts of xScale capacity through 2024.
Equinix opened 14 new data centers in 12 metros including Dublin, Frankfurt, Kuala Lumpur, Madrid, Milan, Montreal, Paris, São Paulo, Seattle, Seoul, Tokyo and Washington, D.C. In addition, the company added seven new projects in Dallas, Lagos, Madrid, Milan, Warsaw and Washington, D.C.
In December, Equinix announced plans to expand support for advanced liquid cooling technologies—including direct-to-chip—to more than 100 of its International Business ExchangeTM (IBX®) data centers in more than 45 metros around the world. This will enable more businesses to use the most performant cooling technologies for the powerful, high-density hardware that supports compute-intensive workloads such as AI.
The surge in demand for hyperscale infrastructure to support AI and cloud initiatives is resulting in strong demand and significant leasing activity for Equinix’s global xScale data center portfolio. Since the last earnings call, the company leased a record 90 megawatts of capacity across six assets in EMEA and APAC, including approximately 32 megawatts leased at the start of the year. This brings total xScale leasing to 300 megawatts globally.
In Q4, Equinix purchased the company’s London 8 IBX data center. Revenues from owned assets increased to 66% of recurring revenues, stepping up 2%, as the company continues to progress on ownership and long-term control of assets.
Last month Equinix launched a fully managed private cloud service that enables enterprises to easily acquire and manage their own NVIDIA DGX AI supercomputing infrastructure for building and running custom generative AI models. The service includes NVIDIA DGX systems, NVIDIA networking and the NVIDIA AI Enterprise software platform. Equinix installs and operates each customer’s privately owned NVIDIA infrastructure and can deploy services on their behalf in key IBX data centers globally.
Equinix continues to gain traction as a preferred location for deploying private AI infrastructure with both enterprises and service providers. In December, the company announced that customers, including Continental AG, i3D.net and Harrison.ai, are leveraging the cloud adjacency, global reach, robust ecosystems and low-latency interconnection of Platform Equinix® to deploy private AI infrastructure.
Equinix’s industry-leading global interconnection franchise continues to perform with over 462,000 total interconnections deployed on its platform. In Q4, interconnection revenues stepped up 10% year-over-year on an as reported basis or 8% year-over-year on a normalized and constant currency basis, and the company added an incremental 4,300 organic interconnections in the quarter.
In Q4, Equinix added four new native cloud on-ramps in Bogotá, Calgary and Zurich, further strengthening its cloud ecosystem. Equinix customers can now enjoy low-latency access to multiple native cloud on-ramps in 37 metros, including eight out of the world’s 10 largest metros by GDP. Equinix has nearly 40% market share of the on-ramps to the major cloud service providers—key players in the AI ecosystem.
The company recently launched Equinix Fabric Cloud Router, a virtual routing service designed to simplify networking challenges for enterprises in cloud-to-cloud and hybrid cloud environments. This service provides an easy-to-configure, enterprise-grade, multicloud routing solution that can be deployed within minutes. Customers can utilize Equinix Fabric Cloud Router in all 58 Equinix Fabric®-enabled metros globally, ensuring low-latency connectivity to major cloud providers and a wide range of service providers.
Equinix’s Channel program continued to see strong momentum, contributing to 35% of bookings and over 50% of new customers in Q4. The company saw growth from partners, including Avant, HCL, HPE, NVIDIA and WWT, with wins across a wide range of industry verticals and digital-first use cases.
Equinix remains committed to advancing its Future First Sustainability strategy and has continued to make significant progress in this area.
In December, Equinix announced the full allocation of proceeds from $4.9 billion in investment-grade green bonds to advance toward its near-term science-based target to become climate neutral by 2030 and improve the operational eco-efficiency of its business. As one of the top ten largest green bond issuers in the U.S., Equinix used the net proceeds to support 172 green building projects across 105 sites, 33 energy-efficiency projects, and two Power Purchase Agreements (“PPAs”).
Earlier this month Equinix executed a new PPA in Australia, signaling a broader industry goal of bringing additional clean power to a region where conditions have traditionally been more challenging for executing renewable energy projects. To date, Equinix has executed 21 PPAs across Australia, France, Iberia, the Nordics and the U.S., representing more than one gigawatt of clean energy once operational.
For the second year in a row, Equinix achieved the highest-ranking score of the CDP’s prestigious 2023 “Climate Change A List,” a leading environmental rating system focused on climate-related transparency and action. Equinix was also named as a leader in the IDC MarketScape: Worldwide Datacenter Services 2023 Vendor Assessment, recognized for its sustainability advancements, innovative platform capabilities, and global expansion and ecosystem growth.1
__________________________________________
1.
IDC, “IDC MarketScape: Worldwide Datacenter Services 2023 Vendor Assessment,” Doc # US49435022e, October 2023
Business Outlook
For the first quarter of 2024, Equinix expects revenues to range between $2.127 and $2.147 billion, an increase of 1 – 2% over the previous quarter, or flat on a normalized and constant currency basis. This guidance includes lower non-recurring revenues related to significant xScale activity in Q4 2023 partly offset by a foreign currency benefit of $38 million when compared to the average FX rates in Q4 2023. Adjusted EBITDA is expected to range between $960 and $980 million, which includes a foreign currency benefit of $18 million when compared to the average FX rates in Q4 2023. Adjusted EBITDA includes $5 million of integration costs related to acquisitions. Recurring capital expenditures are expected to range between $14 and $34 million.
For the full year of 2024, total revenues are expected to range between $8.793 and $8.893 billion, a 7 – 9% increase over the previous year on an as-reported basis, or a 7 – 8% increase on a normalized and constant currency basis excluding the year-over-year impact of the power pass-through, and includes a foreign currency benefit of $127 million when compared to the prior Equinix guidance FX rates. Adjusted EBITDA is expected to range between $4.089 and $4.169 billion, an adjusted EBITDA margin of 47%. This adjusted EBITDA includes approximately 160 basis points of margin benefit from improving operating leverage and power cost decreases, as well as a foreign currency benefit of $67 million when compared to the prior Equinix guidance FX rates. For the year, the company expects to incur $25 million in integration costs related to acquisitions. AFFO is expected to range between $3.306 and $3.376 billion, a 9 – 12% increase over the previous year on both an as-reported and normalized and constant currency basis. This AFFO guidance includes $25 million in integration costs related to acquisitions. AFFO per share is expected to range between $34.58 and $35.31, an 8 – 10% increase over the previous year on both an as-reported and normalized and constant currency basis. This guidance excludes any capital market activities the company may undertake in the future. Non-recurring capital expenditures, including xScale-related costs, are expected to range between $2.570 and $2.800 billion, and recurring capital expenditures are expected to range between $210 and $230 million. xScale-related on-balance sheet capital expenditures are expected to range between $50 and $90 million, which we anticipate will be reimbursed from both the current and future xScale JVs.
The U.S. dollar exchange rates used for 2024 guidance, taking into consideration the impact of our current foreign currency hedges, have been updated to $1.10 to the Euro, $1.24 to the Pound, S$1.32 to the U.S. dollar, ¥141 to the U.S. dollar and A$1.47 to the U.S. dollar. The Q4 2023 global revenue breakdown by currency for the Euro, British Pound, Singapore Dollar, Japanese Yen and Australian Dollar is 21%, 10%, 8%, 5% and 3%, respectively.
The adjusted EBITDA guidance is based on the revenue guidance less our expectations of cash cost of revenues and cash operating expenses. The AFFO guidance is based on the adjusted EBITDA guidance less our expectations of net interest expense, an installation revenue adjustment, a straight-line rent expense adjustment, a contract cost adjustment, amortization of deferred financing costs and debt discounts and premiums, income tax expense, an income tax expense adjustment, recurring capital expenditures, other income (expense), gains (losses) on disposition of real estate property, and adjustments for unconsolidated joint ventures’ and non-controlling interests’ share of these items.
Q4 2023 Results Conference Call and Replay Information
Equinix will discuss its quarterly results for the period ended December 31, 2023, along with its future outlook, in its quarterly conference call on Wednesday, February 14, 2024, at 5:30 p.m. ET (2:30 p.m. PT). A simultaneous live webcast of the call will be available on the company’s Investor Relations website at www.equinix.com/investors. To hear the conference call live, please dial 1-517-308-9482 (domestic and international) and reference the passcode EQIX.
A replay of the call will be available one hour after the call through Wednesday, May 1, 2024, by dialing 1-800-568-3705 and referencing the passcode 2024. In addition, the webcast will be available at www.equinix.com/investors (no password required).
Investor Presentation and Supplemental Financial Information
Equinix has made available on its website a presentation designed to accompany the discussion of Equinix’s results and future outlook, along with certain supplemental financial information and other data. Interested parties may access this information through the Equinix Investor Relations website at www.equinix.com/investors.
Additional Resources
Equinix Investor Relations Resources
About Equinix
Equinix (Nasdaq: EQIX) is the world’s digital infrastructure company®. Digital leaders harness Equinix’s trusted platform to bring together and interconnect foundational infrastructure at software speed. Equinix enables organizations to access all the right places, partners and possibilities to scale with agility, speed the launch of digital services, deliver world-class experiences and multiply their value, while supporting their sustainability goals.
Non-GAAP Financial Measures
Equinix provides all information required in accordance with generally accepted accounting principles (“GAAP”), but it believes that evaluating its ongoing operating results may be difficult if limited to reviewing only GAAP financial measures. Accordingly, Equinix uses non-GAAP financial measures to evaluate its operations.
Equinix provides normalized and constant currency growth rates, which are calculated to adjust for acquisitions, dispositions, integration costs, changes in accounting principles and foreign currency.
Equinix presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA represents net income excluding income tax expense, interest income, interest expense, other income or expense, gain or loss on debt extinguishment, depreciation, amortization, accretion, stock-based compensation expense, restructuring charges, impairment charges, transaction costs and gain or loss on asset sales.
In presenting non-GAAP financial measures, such as adjusted EBITDA, cash cost of revenues, cash gross margins, cash operating expenses (also known as cash selling, general and administrative expenses or cash SG&A), adjusted EBITDA margins, free cash flow and adjusted free cash flow, Equinix excludes certain items that it believes are not good indicators of Equinix’s current or future operating performance. These items are depreciation, amortization, accretion of asset retirement obligations and accrued restructuring charges, stock-based compensation, restructuring charges, impairment charges, transaction costs and gain or loss on asset sales. Equinix excludes these items in order for its lenders, investors and the industry analysts who review and report on Equinix to better evaluate Equinix’s operating performance and cash spending levels relative to its industry sector and competitors.
Equinix excludes depreciation expense as these charges primarily relate to the initial construction costs of a data center, and do not reflect its current or future cash spending levels to support its business. Its data centers are long-lived assets, and have an economic life greater than 10 years. The construction costs of an IBX data center do not recur with respect to such data center, and future capital expenditures remain minor relative to our initial investment throughout its useful life. Construction costs in future periods are primarily incurred with respect to additional IBX data centers. This is a trend we expect to continue. In addition, depreciation is also based on the estimated useful lives of the data centers. These estimates could vary from actual performance of the asset, are based on historic costs incurred to build out our data centers and are not indicative of current or expected future capital expenditures. Therefore, Equinix excludes depreciation from its operating results when evaluating its operations.
In addition, in presenting the non-GAAP financial measures, Equinix also excludes amortization expense related to acquired intangible assets. Amortization expense is significantly affected by the timing and magnitude of acquisitions, and these charges may vary in amount from period to period. We exclude amortization expense to facilitate a more meaningful evaluation of our current operating performance and comparisons to our prior periods. Equinix excludes accretion expense, both as it relates to its asset retirement obligations as well as its accrued restructuring charges, as these expenses represent costs which Equinix also believes are not meaningful in evaluating Equinix’s current operations. Equinix excludes stock-based compensation expense, as it can vary significantly from period to period based on share price and the timing, size and nature of equity awards. As such, Equinix and many investors and analysts exclude stock-based compensation expense to compare its operating results with those of other companies. Equinix excludes restructuring charges from its non-GAAP financial measures. The restructuring charges relate to Equinix’s decision to exit leases for excess space adjacent to several of its IBX® data centers, which it did not intend to build out, or its decision to reverse such restructuring charges. Equinix also excludes impairment charges generally related to certain long-lived assets. The impairment charges are related to expense recognized whenever events or changes in circumstances indicate that the carrying amount of assets are not recoverable. Equinix also excludes gain or loss on asset sales as it represents profit or loss that is not meaningful in evaluating the current or future operating performance. Finally, Equinix excludes transaction costs from its non-GAAP financial measures to allow more comparable comparisons of the financial results to the historical operations. The transaction costs relate to costs Equinix incurs in connection with business combinations and the formation of joint ventures, including advisory, legal, accounting, valuation and other professional or consulting fees. Such charges generally are not relevant to assessing the long-term performance of Equinix. In addition, the frequency and amount of such charges vary significantly based on the size and timing of the transactions. Management believes items such as restructuring charges, impairment charges, transaction costs and gain or loss on asset sales are non-core transactions; however, these types of costs may occur in future periods.
Equinix also presents funds from operations (“FFO”) and adjusted funds from operations (“AFFO”), both commonly used in the REIT industry, as supplemental performance measures. Additionally, Equinix presents AFFO per share, which is also commonly used in the REIT industry. AFFO per share offers investors and industry analysts a perspective of Equinix’s underlying operating performance when compared to other REIT companies. FFO is calculated in accordance with the definition established by the National Association of Real Estate Investment Trusts (“NAREIT”). FFO represents net income or loss, excluding gain or loss from the disposition of real estate assets, depreciation and amortization on real estate assets and adjustments for unconsolidated joint ventures’ and non-controlling interests’ share of these items. AFFO represents FFO, excluding depreciation and amortization expense on non-real estate assets, accretion, stock-based compensation, stock-based charitable contributions, restructuring charges, impairment charges, transaction costs, an installation revenue adjustment, a straight-line rent expense adjustment, a contract cost adjustment, amortization of deferred financing costs and debt discounts and premiums, gain or loss on debt extinguishment, an income tax expense adjustment, recurring capital expenditures, net income or loss from discontinued operations, net of tax, and adjustments from FFO to AFFO for unconsolidated joint ventures’ and non-controlling interests’ share of these items. Equinix excludes depreciation expense, amortization expense, accretion, stock-based compensation, restructuring charges, impairment charges and transaction costs for the same reasons that they are excluded from the other non-GAAP financial measures mentioned above.
Equinix includes an adjustment for revenues from installation fees, since installation fees are deferred and recognized ratably over the period of contract term, although the fees are generally paid in a lump sum upon installation. Equinix includes an adjustment for straight-line rent expense on its operating leases, since the total minimum lease payments are recognized ratably over the lease term, although the lease payments generally increase over the lease term. Equinix also includes an adjustment to contract costs incurred to obtain contracts, since contract costs are capitalized and amortized over the estimated period of benefit on a straight-line basis, although costs of obtaining contracts are generally incurred and paid during the period of obtaining the contracts. The adjustments for installation revenues, straight-line rent expense and contract costs are intended to isolate the cash activity included within the straight-lined or amortized results in the consolidated statement of operations. Equinix excludes the amortization of deferred financing costs and debt discounts and premiums as these expenses relate to the initial costs incurred in connection with its debt financings that have no current or future cash obligations. Equinix excludes gain or loss on debt extinguishment since it represents a cost that is not a good indicator of Equinix’s current or future operating performance. Equinix includes an income tax expense adjustment, which represents the non-cash tax impact due to changes in valuation allowances and uncertain tax positions that do not relate to the current period’s operations. Equinix deducts recurring capital expenditures, which represent expenditures to extend the useful life of its IBX and xScale data centers or other assets that are required to support current revenues. Equinix excludes net income or loss from discontinued operations, net of tax, which represents results that are not a good indicator of our current or future operating performance.
Equinix presents constant currency results of operations, which is a non-GAAP financial measure and is not meant to be considered in isolation or as an alternative to GAAP results of operations. However, Equinix has presented this non-GAAP financial measure to provide investors with an additional tool to evaluate its operating results without the impact of fluctuations in foreign currency exchange rates, thereby facilitating period-to-period comparisons of Equinix’s business performance. To present this information, Equinix’s current and comparative prior period revenues and certain operating expenses from entities with functional currencies other than the U.S. dollar are converted into U.S. dollars at a consistent exchange rate for purposes of each result being compared.
Non-GAAP financial measures are not a substitute for financial information prepared in accordance with GAAP. Non-GAAP financial measures should not be considered in isolation, but should be considered together with the most directly comparable GAAP financial measures and the reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures. Equinix presents such non-GAAP financial measures to provide investors with an additional tool to evaluate its operating results in a manner that focuses on what management believes to be its core, ongoing business operations. Management believes that the inclusion of these non-GAAP financial measures provides consistency and comparability with past reports and provides a better understanding of the overall performance of the business and its ability to perform in subsequent periods. Equinix believes that if it did not provide such non-GAAP financial information, investors would not have all the necessary data to analyze Equinix effectively.
Investors should note that the non-GAAP financial measures used by Equinix may not be the same non-GAAP financial measures, and may not be calculated in the same manner, as those of other companies. Investors should, therefore, exercise caution when comparing non-GAAP financial measures used by us to similarly titled non-GAAP financial measures of other companies. Equinix does not provide forward-looking guidance for certain financial data, such as depreciation, amortization, accretion, stock-based compensation, net income or loss from operations, cash generated from operating activities and cash used in investing activities, and as a result, is not able to provide a reconciliation of GAAP to non-GAAP financial measures for forward-looking data without unreasonable effort. The impact of such adjustments could be significant. Equinix intends to calculate the various non-GAAP financial measures in future periods consistent with how they were calculated for the periods presented within this press release.
Forward-Looking Statements
This press release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from expectations discussed in such forward-looking statements. Factors that might cause such differences include, but are not limited to, risks to our business and operating results related to the current inflationary environment; foreign currency exchange rate fluctuations; increased costs and increased challenges to procure power and the general volatility in the global energy market; the challenges of acquiring, operating and constructing IBX and xScale data centers and developing, deploying and delivering Equinix products and solutions; unanticipated costs or difficulties relating to the integration of companies we have acquired or will acquire into Equinix; a failure to receive significant revenues from customers in recently built out or acquired data centers; failure to complete any financing arrangements contemplated from time to time; competition from existing and new competitors; the ability to generate sufficient cash flow or otherwise obtain funds to repay new or outstanding indebtedness; the loss or decline in business from our key customers; risks related to potential cybersecurity breaches; risks related to our taxation as a REIT and other risks described from time to time in Equinix filings with the Securities and Exchange Commission. In particular, see recent and upcoming Equinix quarterly and annual reports filed with the Securities and Exchange Commission, copies of which are available upon request from Equinix. Equinix does not assume any obligation to update the forward-looking information contained in this press release.
EQUINIX, INC.
Condensed Consolidated Statements of Operations
(in thousands, except per share data)
(unaudited)
Three Months Ended
Twelve Months Ended
December 31,
2023
September 30,
2023
December 31,
2022
December 31,
2023
December 31,
2022
Recurring revenues
$ 1,976,038
$ 1,961,043
$ 1,773,380
$ 7,744,731
$ 6,871,287
Non-recurring revenues
134,451
99,987
97,465
443,405
391,818
Revenues
2,110,489
2,061,030
1,870,845
8,188,136
7,263,105
Cost of revenues
1,091,776
1,068,991
970,700
4,227,658
3,751,501
Gross profit
1,018,713
992,039
900,145
3,960,478
3,511,604
Operating expenses:
Sales and marketing
217,603
212,506
207,233
855,796
786,560
General and administrative
448,849
403,890
400,183
1,654,042
1,498,701
Transaction costs
5,869
(775)
10,529
12,412
21,839
(Gain) loss on asset sales
(24)
(3,933)
—
(5,046)
3,976
Total operating expenses
672,297
611,688
617,945
2,517,204
2,311,076
Income from operations
346,416
380,351
282,200
1,443,274
1,200,528
Interest and other expense:
Interest income
28,225
23,111
18,462
94,227
36,268
Interest expense
(103,183)
(101,385)
(94,200)
(402,022)
(356,337)
Other expense
(1,227)
(5,972)
(28,895)
(11,214)
(51,417)
Gain (loss) on debt extinguishment
71
(360)
143
(35)
327
Total interest and other, net
(76,114)
(84,606)
(104,490)
(319,044)
(371,159)
Income before income taxes
270,302
295,745
177,710
1,124,230
829,369
Income tax expense
(42,825)
(19,985)
(48,807)
(155,250)
(124,792)
Net income
227,477
275,760
128,903
968,980
704,577
Net (income) loss attributable to non-controlling interests
91
34
(140)
198
(232)
Net income attributable to common shareholders
$ 227,568
$ 275,794
$ 128,763
$ 969,178
$ 704,345
Net income per share attributable to common shareholders:
Basic net income per share
$ 2.41
$ 2.94
$ 1.39
$ 10.35
$ 7.69
Diluted net income per share
$ 2.40
$ 2.93
$ 1.39
$ 10.31
$ 7.67
Shares used in computing basic net income per share
94,268
93,683
92,573
93,615
91,569
Shares used in computing diluted net income per share
94,667
94,168
92,752
94,009
91,828
EQUINIX, INC.
Condensed Consolidated Statements of Comprehensive Income (Loss)
(in thousands)
(unaudited)
Three Months Ended
Twelve Months Ended
December 31,
2023
September 30,
2023
December 31,
2022
December 31,
2023
December 31,
2022
Net income
$ 227,477
$ 275,760
$ 128,903
$ 968,980
$ 704,577
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment (“CTA”) gain (loss)
479,754
(412,910)
796,716
249,981
(769,886)
Unrealized gain (loss) on cash flow hedges
(26,382)
25,685
(50,231)
(18,370)
40,543
Net investment hedge CTA gain (loss)
(217,345)
149,608
(379,960)
(131,883)
425,701
Net actuarial loss on defined benefit plans
(112)
(119)
(42)
(462)
(101)
Total other comprehensive income (loss), net of tax
235,915
(237,736)
366,483
99,266
(303,743)
Comprehensive income, net of tax
463,392
38,024
495,386
1,068,246
400,834
Net (income) loss attributable to non-controlling interests
91
34
(140)
198
(232)
Other comprehensive (income) loss attributable to non-controlling interests
(22)
182
(12)
63
48
Comprehensive income attributable to common shareholders
$ 463,461
$ 38,240
$ 495,234
$ 1,068,507
$ 400,650
EQUINIX, INC.
Condensed Consolidated Balance Sheets
(in thousands)
(unaudited)
December 31, 2023
December 31, 2022
Assets
Cash and cash equivalents
$ 2,095,712
$ 1,906,421
Accounts receivable, net
1,003,792
855,380
Other current assets
468,193
459,138
Assets held for sale
—
84,316
Total current assets
3,567,697
3,305,255
Property, plant and equipment, net
18,600,833
16,649,534
Operating lease right-of-use assets
1,448,890
1,427,950
Goodwill
5,737,122
5,654,217
Intangible assets, net
1,704,870
1,897,649
Other assets
1,591,312
1,376,137
Total assets
$ 32,650,724
$ 30,310,742
Liabilities, Redeemable Non-Controlling Interest and Stockholders’ Equity
Accounts payable and accrued expenses
$ 1,186,618
$ 1,004,800
Accrued property, plant and equipment
398,216
281,347
Current portion of operating lease liabilities
130,745
139,538
Current portion of finance lease liabilities
138,657
151,420
Current portion of mortgage and loans payable
7,705
9,847
Current portion of senior notes
998,580
—
Other current liabilities
301,729
251,346
Total current liabilities
3,162,250
1,838,298
Operating lease liabilities, less current portion
1,331,333
1,272,812
Finance lease liabilities, less current portion
2,122,484
2,143,690
Mortgage and loans payable, less current portion
663,263
642,708
Senior notes, less current portion
12,062,346
12,109,539
Other liabilities
795,549
797,863
Total liabilities
20,137,225
18,804,910
Redeemable non-controlling interest
25,000
—
Common stockholders’ equity:
Common stock
95
93
Additional paid-in capital
18,595,664
17,320,017
Treasury stock
(56,117)
(71,966)
Accumulated dividends
(8,694,647)
(7,317,570)
Accumulated other comprehensive loss
(1,290,117)
(1,389,446)
Retained earnings
3,934,016
2,964,838
Total common stockholders’ equity
12,488,894
11,505,966
Non-controlling interests
(395)
(134)
Total stockholders’ equity
12,488,499
11,505,832
Total liabilities, redeemable non-controlling interest and stockholders’ equity
$ 32,650,724
$ 30,310,742
Ending headcount by geographic region is as follows:
Americas headcount
5,953
5,493
EMEA headcount
4,267
3,936
Asia-Pacific headcount
2,931
2,668
Total headcount
13,151
12,097
EQUINIX, INC.
Summary of Debt Principal Outstanding
(in thousands)
(unaudited)
December 31, 2023
December 31, 2022
Finance lease liabilities
$ 2,261,141
$ 2,295,110
Term loans
641,931
618,028
Mortgage payable and other loans payable
29,037
34,527
Plus: debt discount and issuance costs, net
726
1,062
Total mortgage and loans payable principal
671,694
653,617
Senior notes
13,060,926
12,109,539
Plus: debt discount and issuance costs
108,026
117,351
Total senior notes principal
13,168,952
12,226,890
Total debt principal outstanding
$ 16,101,787
$ 15,175,617
EQUINIX, INC.
Condensed Consolidated Statements of Cash Flows
(in thousands)
(unaudited)
Three Months Ended
Twelve Months Ended
December 31,
2023
September 30,
2023
December 31,
2022
December 31,
2023
December 31,
2022
Cash flows from operating activities:
Net income
$ 227,477
$ 275,760
$ 128,903
$ 968,980
$ 704,577
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and accretion
462,367
466,613
438,492
1,843,665
1,739,374
Stock-based compensation
105,829
98,446
107,519
407,536
403,983
Amortization of debt issuance costs and debt discounts and premiums
4,791
4,684
4,553
18,718
17,826
(Gain) loss on debt extinguishment
(71)
360
(143)
35
(327)
Loss (gain) on asset sales
(24)
(3,933)
—
(5,046)
3,976
Other items
15,788
12,776
44,880
58,030
67,298
Changes in operating assets and liabilities:
Accounts receivable
49,358
(47,147)
(56,209)
(150,345)
(153,415)
Income taxes, net
10,692
(14,530)
(17,701)
4,107
(7,827)
Accounts payable and accrued expenses
76,351
69,082
31,511
161,300
114,600
Operating lease right-of-use assets
21,624
39,977
36,171
138,704
149,094
Operating lease liabilities
(27,575)
(33,654)
(34,586)
(126,539)
(132,831)
Other assets and liabilities
52,107
(83,259)
76,799
(102,550)
56,854
Net cash provided by operating activities
998,714
785,175
760,189
3,216,595
2,963,182
Cash flows from investing activities:
Purchases, sales and maturities of investments, net
(54,534)
(26,664)
(35,222)
(135,881)
(122,569)
Business acquisitions, net of cash and restricted cash acquired
—
—
—
—
(964,010)
Real estate acquisitions
(231,108)
(112,896)
(208,377)
(384,401)
(248,276)
Purchases of other property, plant and equipment
(995,720)
(617,539)
(827,927)
(2,781,018)
(2,278,004)
Proceeds from asset sales
—
4,682
—
76,936
249,906
Net cash used in investing activities
(1,281,362)
(752,417)
(1,071,526)
(3,224,364)
(3,362,953)
Cash flows from financing activities:
Proceeds from employee equity awards
(115)
42,420
—
86,848
81,543
Proceeds from redeemable non-controlling interest
—
—
—
25,000
—
Payment of dividend distributions
(403,176)
(324,587)
(287,573)
(1,374,168)
(1,151,459)
Proceeds from public offering of common stock, net of offering costs
432,876
—
—
733,651
796,018
Proceeds from mortgage and loans payable
—
—
—
—
676,850
Proceeds from senior notes, net of debt discounts
—
336,853
—
902,092
1,193,688
Repayment of finance lease liabilities
(50,822)
(31,629)
(36,394)
(148,913)
(134,202)
Repayment of mortgage and loans payable
(576)
(2,133)
(1,714)
(6,132)
(587,941)
Repayment of senior notes
—
—
—
—
—
Debt extinguishment costs
—
—
—
—
—
Debt issuance costs
307
(2,982)
—
(6,932)
(17,731)
Net cash provided by (used in) financing activities
(21,506)
17,942
(325,681)
211,446
856,766
Effect of foreign currency exchange rates on cash, cash equivalents and restricted cash
42,209
(35,027)
37,398
(15,616)
(98,201)
Net increase (decrease) in cash, cash equivalents and restricted cash
(261,945)
15,673
(599,620)
188,061
358,794
Cash, cash equivalents and restricted cash at beginning of period
2,358,254
2,342,581
2,507,868
1,908,248
1,549,454
Cash, cash equivalents and restricted cash at end of period
$ 2,096,309
$ 2,358,254
$ 1,908,248
$ 2,096,309
$ 1,908,248
Supplemental cash flow information:
Cash paid for taxes
$ 26,662
$ 42,021
$ 44,091
$ 152,988
$ 140,312
Cash paid for interest
$ 136,224
$ 97,152
$ 128,511
$ 471,456
$ 430,217
Free cash flow (negative free cash flow)(1)
$ (228,114)
$ 59,422
$ (276,115)
$ 128,112
$ (277,202)
Adjusted free cash flow (2)
$ 2,994
$ 172,318
$ (67,738)
$ 512,513
$ 935,084
(1)
We define free cash flow (negative free cash flow) as net cash provided by operating activities plus net cash provided by (used in) investing activities (excluding the net purchases, sales and maturities of investments) as presented below:
Net cash provided by operating activities as presented above
$ 998,714
$ 785,175
$ 760,189
$ 3,216,595
$ 2,963,182
Net cash used in investing activities as presented above
(1,281,362)
(752,417)
(1,071,526)
(3,224,364)
(3,362,953)
Purchases, sales and maturities of investments, net
54,534
26,664
35,222
135,881
122,569
Free cash flow (negative free cash flow)
$ (228,114)
$ 59,422
$ (276,115)
$ 128,112
$ (277,202)
(2)
We define adjusted free cash flow as free cash flow (negative free cash flow) as defined above, excluding any real estate and business acquisitions, net of cash and restricted cash acquired as presented below:
Free cash flow (negative free cash flow) as defined above
$ (228,114)
$ 59,422
$ (276,115)
$ 128,112
$ (277,202)
Less business acquisitions, net of cash and restricted cash acquired
—
—
—
—
964,010
Less real estate acquisitions
231,108
112,896
208,377
384,401
248,276
Adjusted free cash flow
$ 2,994
$ 172,318
$ (67,738)
$ 512,513
$ 935,084
EQUINIX, INC.
Non-GAAP Measures and Other Supplemental Data
(in thousands)
(unaudited)
Three Months Ended
Twelve Months Ended
December 31, 2023
September 30, 2023
December 31, 2022
December 31, 2023
December 31, 2022
Recurring revenues
$ 1,976,038
$ 1,961,043
$ 1,773,380
$ 7,744,731
$ 6,871,287
Non-recurring revenues
134,451
99,987
97,465
443,405
391,818
Revenues (1)
2,110,489
2,061,030
1,870,845
8,188,136
7,263,105
Cash cost of revenues (2)
756,510
725,750
642,176
2,869,034
2,436,074
Cash gross profit (3)
1,353,979
1,335,280
1,228,669
5,319,102
4,827,031
Cash operating expenses (4)(7):
Cash sales and marketing expenses (5)
147,084
138,879
140,697
567,514
506,609
Cash general and administrative
expenses (6)
286,438
260,470
249,232
1,049,747
950,722
Total cash operating expenses (4)(7)
433,522
399,349
389,929
1,617,261
1,457,331
Adjusted EBITDA (8)
$ 920,457
$ 935,931
$ 838,740
$ 3,701,841
$ 3,369,700
Cash gross margins (9)
64 %
65 %
66 %
65 %
66 %
Adjusted EBITDA
margins (10)
44 %
45 %
45 %
45 %
46 %
Adjusted EBITDA flow-through rate (11)
(31) %
82 %
(107) %
36 %
36 %
FFO (12)
$ 524,505
$ 562,080
$ 406,945
$ 2,129,977
$ 1,826,334
AFFO (13) (14)
$ 690,846
$ 771,617
$ 657,818
$ 3,018,518
$ 2,713,878
Basic FFO per share (15)
$ 5.56
$ 6.00
$ 4.40
$ 22.75
$ 19.94
Diluted FFO per share (15)
$ 5.54
$ 5.97
$ 4.39
$ 22.66
$ 19.89
Basic AFFO per share (15)
$ 7.33
$ 8.24
$ 7.11
$ 32.24
$ 29.64
Diluted AFFO per share(15)
$ 7.30
$ 8.19
$ 7.09
$ 32.11
$ 29.55
(1)
The geographic split of our revenues on a services basis is presented below:
Americas Revenues:
Colocation
$ 610,512
$ 596,871
$ 568,240
$ 2,365,049
$ 2,187,751
Interconnection
210,550
206,552
197,337
820,007
756,214
Managed infrastructure
65,024
63,356
59,244
249,779
218,499
Other
6,657
5,503
4,885
22,118
20,727
Recurring revenues
892,743
872,282
829,706
3,456,953
3,183,191
Non-recurring revenues
38,968
41,411
42,065
160,539
166,026
Revenues
$ 931,711
$ 913,693
$ 871,771
$ 3,617,492
$ 3,349,217
EMEA Revenues:
Colocation
$ 540,935
$ 538,256
$ 450,480
$ 2,112,168
$ 1,744,121
Interconnection
79,619
78,795
66,710
307,337
268,398
Managed infrastructure
32,956
32,790
29,431
130,061
119,361
Other
23,816
23,283
23,882
98,591
75,449
Recurring revenues
677,326
673,124
570,503
2,648,157
2,207,329
Non-recurring revenues
73,840
35,590
31,208
189,697
135,875
Revenues
$ 751,166
$ 708,714
$ 601,711
$ 2,837,854
$ 2,343,204
Asia-Pacific Revenues:
Colocation
$ 317,969
$ 329,054
$ 291,480
$ 1,288,844
$ 1,150,738
Interconnection
67,538
67,411
61,572
266,966
243,664
Managed infrastructure
17,191
17,484
17,819
71,833
77,646
Other
3,271
1,688
2,300
11,978
8,719
Recurring revenues
405,969
415,637
373,171
1,639,621
1,480,767
Non-recurring revenues
21,643
22,986
24,192
93,169
89,917
Revenues
$ 427,612
$ 438,623
$ 397,363
$ 1,732,790
$ 1,570,684
Worldwide Revenues:
Colocation
$ 1,469,416
$ 1,464,181
$ 1,310,200
$ 5,766,061
$ 5,082,610
Interconnection
357,707
352,758
325,619
1,394,310
1,268,276
Managed infrastructure
115,171
113,630
106,494
451,673
415,506
Other
33,744
30,474
31,067
132,687
104,895
Recurring revenues
1,976,038
1,961,043
1,773,380
7,744,731
6,871,287
Non-recurring revenues
134,451
99,987
97,465
443,405
391,818
Revenues
$ 2,110,489
$ 2,061,030
$ 1,870,845
$ 8,188,136
$ 7,263,105
(2)
We define cash cost of revenues as cost of revenues less depreciation, amortization, accretion and stock-based compensation as presented below:
Cost of revenues
$ 1,091,776
$ 1,068,991
$ 970,700
$ 4,227,658
$ 3,751,501
Depreciation, amortization and accretion expense
(322,366)
(330,852)
(316,549)
(1,309,613)
(1,270,399)
Stock-based compensation expense
(12,900)
(12,389)
(11,975)
(49,011)
(45,028)
Cash cost of revenues
$ 756,510
$ 725,750
$ 642,176
$ 2,869,034
$ 2,436,074
The geographic split of our cash cost of revenues is presented below:
Americas cash cost of revenues
$ 263,165
$ 270,272
$ 263,374
$ 1,045,526
$ 994,389
EMEA cash cost of revenues
326,137
304,345
226,574
1,199,345
866,292
Asia-Pacific cash cost of revenues
167,208
151,133
152,228
624,163
575,393
Cash cost of revenues
$ 756,510
$ 725,750
$ 642,176
$ 2,869,034
$ 2,436,074
(3)
We define cash gross profit as revenues less cash cost of revenues (as defined above).
(4)
We define cash operating expense as selling, general, and administrative expense less depreciation, amortization, and stock-based compensation. We also refer to cash operating expense as cash selling, general and administrative expense or “cash SG&A”.
Selling, general, and administrative expense
$ 666,452
$ 616,396
$ 607,416
$ 2,509,838
$ 2,285,261
Depreciation and amortization expense
(140,001)
(130,990)
(121,943)
(534,052)
(468,975)
Stock-based compensation expense
(92,929)
(86,057)
(95,544)
(358,525)
(358,955)
Cash operating expense
$ 433,522
$ 399,349
$ 389,929
$ 1,617,261
$ 1,457,331
(5)
We define cash sales and marketing expense as sales and marketing expense less depreciation, amortization and stock-based compensation as presented below:
Sales and marketing expense
$ 217,603
$ 212,506
$ 207,233
$ 855,796
$ 786,560
Depreciation and amortization expense
(50,632)
(50,989)
(49,604)
(203,698)
(197,157)
Stock-based compensation expense
(19,887)
(22,638)
(16,932)
(84,584)
(82,794)
Cash sales and marketing expense
$ 147,084
$ 138,879
$ 140,697
$ 567,514
$ 506,609
(6)
We define cash general and administrative expense as general and administrative expense less depreciation, amortization and stock-based compensation as presented below:
General and administrative expense
$ 448,849
$ 403,890
$ 400,183
$ 1,654,042
$ 1,498,701
Depreciation and amortization expense
(89,369)
(80,001)
(72,339)
(330,354)
(271,818)
Stock-based compensation expense
(73,042)
(63,419)
(78,612)
(273,941)
(276,161)
Cash general and administrative expense
$ 286,438
$ 260,470
$ 249,232
$ 1,049,747
$ 950,722
(7)
The geographic split of our cash operating expense, or cash SG&A, as defined above, is presented below:
Americas cash SG&A
$ 257,581
$ 238,524
$ 214,560
$ 958,270
$ 833,053
EMEA cash SG&A
105,253
94,197
104,648
387,233
367,410
Asia-Pacific cash SG&A
70,688
66,628
70,721
271,758
256,868
Cash SG&A
$ 433,522
$ 399,349
$ 389,929
$ 1,617,261
$ 1,457,331
(8)
We define adjusted EBITDA as income from operations excluding depreciation, amortization, accretion, stock-based compensation, restructuring charges, impairment charges, transaction costs and gain or loss on asset sales as presented below:
Net income
$ 227,477
$ 275,760
$ 128,903
$ 968,980
$ 704,577
Income tax expense
42,825
19,985
48,807
155,250
124,792
Interest income
(28,225)
(23,111)
(18,462)
(94,227)
(36,268)
Interest expense
103,183
101,385
94,200
402,022
356,337
Other expense
1,227
5,972
28,895
11,214
51,417
(Gain) loss on debt extinguishment
(71)
360
(143)
35
(327)
Depreciation, amortization and accretion expense
462,367
461,842
438,492
1,843,665
1,739,374
Stock-based compensation expense
105,829
98,446
107,519
407,536
403,983
Transaction costs
5,869
(775)
10,529
12,412
21,839
(Gain) loss on asset sales
(24)
(3,933)
—
(5,046)
3,976
Adjusted EBITDA
$ 920,457
$ 935,931
$ 838,740
$ 3,701,841
$ 3,369,700
The geographic split of our adjusted EBITDA is presented below:
Americas net income (loss)
$ 57,548
$ 37,911
$ (67,580)
$ 12,703
$ (584)
Americas income tax expense (benefit)
(89,606)
19,897
(33,279)
22,818
42,587
Americas interest income
(20,633)
(17,506)
(16,259)
(71,945)
(32,265)
Americas interest expense
87,827
86,691
83,363
342,690
316,934
Americas other (income) expense
50,797
(39,137)
104,539
24,752
(42,895)
Americas loss on debt extinguishment
—
—
—
—
198
Americas depreciation, amortization and accretion expense
251,276
251,855
237,919
999,832
932,892
Americas stock-based compensation expense
70,914
64,067
76,131
272,259
282,997
Americas transaction costs
2,923
1,054
9,003
7,064
17,950
Americas (gain) loss on asset sales
(82)
65
—
3,523
3,961
Americas adjusted EBITDA
$ 410,964
$ 404,897
$ 393,837
$ 1,613,696
$ 1,521,775
EMEA net income
$ 174,108
$ 125,992
$ 195,224
$ 651,057
$ 477,808
EMEA income tax expense
49,560
—
16,531
49,560
16,650
EMEA interest income
(3,903)
(2,730)
(1,251)
(12,045)
(2,530)
EMEA interest expense
4,530
3,931
2,675
17,167
5,698
EMEA other (income) expense
(53,621)
42,284
(77,880)
(30,679)
77,705
EMEA depreciation, amortization and accretion expense
124,536
125,613
116,097
497,924
459,098
EMEA stock-based compensation expense
21,271
20,958
18,840
82,575
73,294
EMEA transaction costs
3,238
(1,878)
253
4,286
2,016
EMEA (gain) loss on asset sales
58
(3,998)
—
(8,569)
(237)
EMEA adjusted EBITDA
$ 319,777
$ 310,172
$ 270,489
$ 1,251,276
$ 1,109,502
Asia-Pacific net income (loss)
$ (4,179)
$ 111,857
$ 1,259
$ 305,220
$ 227,353
Asia-Pacific income tax expense
82,871
88
65,555
82,872
65,555
Asia-Pacific interest income
(3,689)
(2,875)
(952)
(10,237)
(1,473)
Asia-Pacific interest expense
10,826
10,763
8,162
42,165
33,705
Asia-Pacific other expense
4,051
2,825
2,236
17,141
16,607
Asia-Pacific (gain) loss on debt extinguishment
(71)
360
(143)
35
(525)
Asia-Pacific depreciation, amortization and accretion expense
86,555
84,374
84,476
345,909
347,384
Asia-Pacific stock-based compensation expense
13,644
13,421
12,548
52,702
47,692
Asia-Pacific transaction costs
(292)
49
1,273
1,062
1,873
Asia-Pacific loss on asset sales
—
—
—
—
252
Asia-Pacific adjusted EBITDA
$ 189,716
$ 220,862
$ 174,414
$ 836,869
$ 738,423
(9)
We define cash gross margins as cash gross profit divided by revenues.
Our cash gross margins by geographic region is presented below:
Americas cash gross margins
72 %
70 %
70 %
71 %
70 %
EMEA cash gross margins
57 %
57 %
62 %
58 %
63 %
Asia-Pacific cash gross margins
61 %
66 %
62 %
64 %
63 %
(10)
We define adjusted EBITDA margins as adjusted EBITDA divided by revenues.
Americas adjusted EBITDA margins
44 %
44 %
45 %
45 %
45 %
EMEA adjusted EBITDA margins
43 %
44 %
45 %
44 %
47 %
Asia-Pacific adjusted EBITDA margins
44 %
50 %
44 %
48 %
47 %
(11)
We define adjusted EBITDA flow-through rate as incremental adjusted EBITDA growth divided by incremental revenue growth as follows:
Adjusted EBITDA – current period
$ 920,457
$ 935,931
$ 838,740
$ 3,701,841
$ 3,369,700
Less adjusted EBITDA – prior period
(935,931)
(901,170)
(870,916)
(3,369,700)
(3,144,384)
Adjusted EBITDA growth
$ (15,474)
$ 34,761
$ (32,176)
$ 332,141
$ 225,316
Revenues – current period
$ 2,110,489
$ 2,061,030
$ 1,870,845
$ 8,188,136
$ 7,263,105
Less revenues – prior period
(2,061,030)
(2,018,408)
(1,840,659)
(7,263,105)
(6,635,537)
Revenue growth
$ 49,459
$ 42,622
$ 30,186
$ 925,031
$ 627,568
Adjusted EBITDA flow-through rate
(31) %
82 %
(107) %
36 %
36 %
(12)
FFO is defined as net income or loss, excluding gain or loss from the disposition of real estate assets, depreciation and amortization on real estate assets and adjustments for unconsolidated joint ventures’ and non-controlling interests’ share of these items.
Net income
$ 227,477
$ 275,760
$ 128,903
$ 968,980
$ 704,577
Net (income) loss attributable to non-controlling interests
91
34
(140)
198
(232)
Net income attributable to common shareholders
227,568
275,794
128,763
969,178
704,345
Adjustments:
Real estate depreciation
289,747
284,760
274,625
1,141,861
1,104,787
(Gain) loss on disposition of real estate property
1,642
(3,480)
437
1,898
7,134
Adjustments for FFO from unconsolidated joint ventures
5,548
5,006
3,120
17,040
10,068
FFO attributable to common shareholders
$ 524,505
$ 562,080
$ 406,945
$ 2,129,977
$ 1,826,334
(13)
AFFO is defined as FFO, excluding depreciation and amortization expense on non-real estate assets, accretion, stock-based compensation, stock-based charitable contributions, restructuring charges, impairment charges, transaction costs, an installation revenue adjustment, a straight-line rent expense adjustment, a contract cost adjustment, amortization of deferred financing costs and debt discounts and premiums, gain or loss on debt extinguishment, an income tax expense adjustment, net income or loss from discontinued operations, net of tax, recurring capital expenditures and adjustments from FFO to AFFO for unconsolidated joint ventures’ and non-controlling interests’ share of these items.
FFO attributable to common shareholders
$ 524,505
$ 562,080
$ 406,945
$ 2,129,977
$ 1,826,334
Adjustments:
Installation revenue adjustment
507
(481)
6,975
3,910
17,745
Straight-line rent expense adjustment
(5,952)
6,323
1,585
12,164
16,263
Amortization of deferred financing costs and debt discounts
4,792
4,684
4,553
18,719
17,826
Contract cost adjustment
(16,349)
(9,835)
(17,380)
(46,601)
(52,888)
Stock-based compensation expense
105,829
98,446
107,519
407,536
403,983
Stock-based charitable contributions
—
—
34,974
2,543
49,013
Non-real estate depreciation expense
121,852
125,882
111,342
494,214
426,666
Amortization expense
51,864
52,297
51,438
209,063
204,755
Accretion expense
(1,096)
(1,097)
1,086
(1,473)
3,166
Recurring capital expenditures
(105,150)
(51,736)
(80,047)
(218,287)
(188,885)
(Gain) loss on debt extinguishment
(71)
360
(143)
35
(327)
Transaction costs
5,869
(775)
10,529
12,412
21,839
Impairment charges (1)
—
1,518
—
1,518
1,815
Income tax expense (benefit) adjustment (1)
1,462
(16,719)
19,806
(12,133)
(31,165)
Adjustments for AFFO from unconsolidated joint ventures
2,784
670
(1,364)
4,921
(2,262)
AFFO attributable to common shareholders
$ 690,846
$ 771,617
$ 657,818
$ 3,018,518
$ 2,713,878
(1) Impairment charges relate to the impairment of an indemnification asset resulting from the settlement of a pre-acquisition uncertain tax position, which was recorded as Other Income (Expense) on the Condensed Consolidated Statements of Operations. This impairment charge was offset by the recognition of tax benefits in the same amount, which was included within the Income tax expense adjustment line on the table above.
(14)
Below is how we reconcile from adjusted EBITDA to AFFO:
Adjusted EBITDA
$ 920,457
$ 935,931
$ 838,740
$ 3,701,841
$ 3,369,700
Adjustments:
Interest expense, net of interest income
(74,958)
(78,274)
(75,738)
(307,795)
(320,069)
Amortization of deferred financing costs and debt discounts
4,792
4,684
4,553
18,719
17,826
Income tax expense
(42,825)
(19,985)
(48,807)
(155,250)
(124,792)
Income tax expense (benefit) adjustment (1)
1,462
(16,719)
19,806
(12,133)
(31,165)
Straight-line rent expense adjustment
(5,952)
6,323
1,585
12,164
16,263
Stock-based charitable contributions
—
—
34,974
2,543
49,013
Contract cost adjustment
(16,349)
(9,835)
(17,380)
(46,601)
(52,888)
Installation revenue adjustment
507
(481)
6,975
3,910
17,745
Recurring capital expenditures
(105,150)
(51,736)
(80,047)
(218,287)
(188,885)
Other expense
(1,227)
(5,972)
(28,895)
(11,214)
(51,417)
(Gain) loss on disposition of real estate property
1,642
(3,480)
437
1,898
7,134
Adjustments for unconsolidated JVs’ and non-controlling interests
8,423
5,710
1,615
22,159
7,574
Adjustments for impairment charges (1)
—
1,518
—
1,518
1,815
Adjustment for gain (loss) on sale of assets
24
3,933
—
5,046
(3,976)
AFFO attributable to common shareholders
$ 690,846
$ 771,617
$ 657,818
$ 3,018,518
$ 2,713,878
(1) Impairment charges relate to the impairment of an indemnification asset resulting from the settlement of a pre-acquisition uncertain tax position, which was recorded as Other Income (Expense) on the Condensed Consolidated Statements of Operations. This impairment charge was offset by the recognition of tax benefits in the same amount, which was included within the Income tax expense adjustment line on the table above.
(15)
The shares used in the computation of basic and diluted FFO and AFFO per share attributable to common shareholders is presented below:
Shares used in computing basic net income per share, FFO per share and AFFO per share
94,268
93,683
92,573
93,615
91,569
Effect of dilutive securities:
Employee equity awards
399
485
179
394
259
Shares used in computing diluted net income per share, FFO per share and AFFO per share
94,667
94,168
92,752
94,009
91,828
Basic FFO per share
$ 5.56
$ 6.00
$ 4.40
$ 22.75
$ 19.94
Diluted FFO per share
$ 5.54
$ 5.97
$ 4.39
$ 22.66
$ 19.89
Basic AFFO per share
$ 7.33
$ 8.24
$ 7.11
$ 32.24
$ 29.64
Diluted AFFO per share
$ 7.30
$ 8.19
$ 7.09
$ 32.11
$ 29.55
View original content to download multimedia:https://www.prnewswire.com/news-releases/equinix-reports-fourth-quarter-and-full-year-2023-results-302062112.html
SOURCE Equinix, Inc.
You may like
Technology
Amid Rising Costs and Surgical Disruptions in ASCs, NorthStar Anesthesia Strengthens Focus on ASC Partnerships
Published
23 minutes agoon
October 23, 2026By
With 17 new ASC partnerships nationwide to date in 2026, NorthStar Anesthesia emphasizes proactive patient assessment, reliable staffing, and clinical consistency to help surgery centers reduce preventable cancellations and maximize surgical capacity.
IRVING, Texas, Oct. 23, 2026 /PRNewswire/ — As ambulatory surgery centers (ASCs) face mounting financial pressures, staffing challenges, and increasingly complex patient needs, anesthesia has emerged as a critical partner in their ability to operate efficiently and sustainably. NorthStar Anesthesia is addressing these challenges through a dedicated ASC model designed to reduce preventable case cancellations, improve surgical throughput, and help centers make the most of their existing operating room capacity.
“The challenge for ASCs today isn’t simply finding anesthesia coverage. It’s ensuring that coverage translates into reliable surgical capacity,” said Cindy Myers, Vice President of ASC Operations at NorthStar Anesthesia. “When cases are cancelled unnecessarily or operating rooms aren’t running as planned, the impact extends well beyond the anesthesia department. Our focus is on helping centers address those challenges systematically, so they can deliver more consistent care and operate more efficiently.”
Reducing Preventable Cancellations Through Better Preparation
One of the most significant opportunities to improve ASC performance lies in the preoperative process. When potential anesthesia concerns are not identified until the day of surgery, patients may face unexpected cancellations, surgeons lose valuable operating time, and centers absorb the cost of unused capacity.
NorthStar addresses this challenge through ASC-specific pre-anesthesia testing (PAT) guidelines and standardized clinical protocols designed to identify potential issues earlier, facilitate appropriate patient optimization, and support consistent decision-making across the surgical process.
“In ambulatory surgery, the decisions made before the patient arrives are often just as important as those made in the operating room,” said Gajan Mahendran, MD, Vice President of Physician Services at NorthStar Anesthesia. “A consistent, evidence-based approach to preoperative assessment helps us identify risks earlier, determine which patients are appropriate for the ASC setting, and address potential barriers to surgery in advance. That means fewer last-minute surprises and a better experience for patients, surgeons, and facilities.”
Aligning Anesthesia Resources With Surgical Demand
Alongside clinical challenges, ASCs are navigating a changing economic environment. In a recent Becker’s ASC Review interview, NorthStar CEO Adam Spiegel noted that approximately 80% of ASCs in NorthStar’s network now require anesthesia stipends, compared with just 10% to 15% before the pandemic.
As anesthesia costs rise, ensuring that staffing levels align with actual surgical demand has become increasingly important. NorthStar works with ASC partners to develop staffing models that reflect each facility’s case mix, surgical volume, and operating requirements. “Adding anesthesia resources doesn’t automatically improve performance if those resources aren’t aligned with the center’s surgical volume,” Myers said. “We work closely with our partners to understand their schedules, case mix, and operational needs so we can build a model that supports both reliable access to care and financial sustainability.”
Combining National Resources With Local Clinical Expertise
As ASCs take on a greater share of surgical procedures, the demands placed on anesthesia providers are becoming more complex. Smaller or locally managed anesthesia groups may face challenges maintaining consistent coverage, recruiting clinicians, or investing in standardized clinical and operational processes.
NorthStar’s model combines local clinical leadership with national recruiting capabilities, dedicated ASC operations expertise, and established quality guidelines. This infrastructure helps support continuity of care, consistent clinical practices, and the flexibility to respond to changes in surgical demand.
The approach is reflected in NorthStar’s expanding ASC partnerships. To date in 2026 alone, NorthStar has added 17 ASC partnerships, including CarePlex Orthopaedic Ambulatory Surgery Center in Norfolk, Virginia; Stony Point Surgery Center and West Creek Surgery Center, both part of MedRVA Healthcare in Richmond, Virginia; an Orthopedic Surgery Center in Wisconsin; Eye Surgery Center of Homewood in Homewood, Alabama; and The Toledo Clinic ASC in Toledo, Ohio.
These partnerships reflect the growing importance of anesthesia providers that can address both the clinical and operational needs of outpatient surgery centers.
To learn more and to request a confidential anesthesia program assessment, please contact James Bagliani, Director of Business Development, NorthStar Anesthesia at james.bagliani@northstaranesthesia.com.
About NorthStar Anesthesia
NorthStar Anesthesia is a company of caregivers, founded by an anesthesiologist and a Certified Registered Nurse Anesthetist (CRNA). With more than 4,000 anesthesiologists and CRNAs under its banner, NorthStar partners with more than 280 healthcare client sites across more than 20 states and counting to deliver a more productive and efficient model of anesthesia care. Its care team approach focuses on the provision of high-quality care while measurably improving operating room performance.
Media Contact: James Bagliani, Director of Business Development, NorthStar Anesthesia james.bagliani@northstaranesthesia.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/amid-rising-costs-and-surgical-disruptions-in-ascs-northstar-anesthesia-strengthens-focus-on-asc-partnerships-302918226.html
SOURCE NorthStar Anesthesia
Technology
Dimethylaminopropylamine Market to Reach USD 731.9 Million by 2035 on Surfactant and Epoxy Demand, Credence Research Finds
Published
23 minutes agoon
October 23, 2026By
LONDON, Oct. 23, 2026 /PRNewswire/ — Credence Research Inc. has added the “Dimethylaminopropylamine Market – Growth, Share, Opportunities & Competitive Analysis, 2025–2035” study to its market intelligence portfolio. The report examines market value, segmentation, demand drivers, regional dynamics, competition and recent industry developments.
The dimethylaminopropylamine (DMAPA) market was valued at USD 452.6 million in 2025 and is projected to reach USD 731.9 million by 2035, representing a 4.92% compound annual growth rate over 2025–2035, according to Credence Research. The firm estimates 2026 revenue at USD 474.3 million. Asia Pacific accounted for the largest modeled geographic share at 44.0% in 2025, while Asia Pacific is projected to grow fastest at 5.88% annually. Market sizes, regional shares and segment shares are Credence Research estimates rather than independently audited industry totals.
Key Takeaways
The market is forecast to increase from USD 452.6 million in 2025 to USD 731.9 million by 2035, with a reported CAGR of 4.92%.Asia Pacific led the modeled 2025 geography with 44.0%; Asia Pacific has the fastest forecast geographic growth of 5.88%.By application, Surfactants accounted for 61.0% of modeled 2025 value, while Epoxy curing agents is forecast to grow at 5.66% a year.By end-use industry, Personal care and cosmetics accounted for 44.0% of modeled 2025 value, while Paints, coatings and composites is forecast to grow at 5.61% a year.The market definition excludes adjacent product or transaction value where that spending is outside the report’s measured scope.
Scope & Segmentation – Dimethylaminopropylamine Market
The study values sales of 3-(dimethylamino)-1-propylamine, an amine intermediate produced from dimethylamine and acrylonitrile. Included uses span betaine and amine-oxide surfactants, epoxy curing agents, polyurethane catalysts, water treatment chemicals, agrochemical intermediates and lubricant additives. Finished surfactants, coatings and other downstream products are excluded from the DMAPA revenue estimate.
By application: Surfactants (betaines and amine oxides); Epoxy curing agents; Polyurethane catalysts; Water treatment chemicals; Agrochemical intermediates; Fuel and lubricant additives; Others.By end-use industry: Personal care and cosmetics; Home care and institutional cleaning; Paints, coatings and composites; Water treatment; Agriculture; Automotive and lubricants.By geography: Asia Pacific; Europe; North America; Latin America; Middle East and Africa.
Read the complete report and request a sample: https://www.credenceresearch.com/report/dimethylaminopropylamine-market
Why This Report Matters
The study distinguishes a narrowly defined revenue pool from adjacent activity that can inflate comparisons between research estimates. This helps strategy teams compare suppliers, customer budgets and product categories on a consistent basis.The base-year segment mix identifies where current purchasing is concentrated, while the modeled faster-growing categories help evaluate investment timing and market entry.Geographic shares are proprietary estimates; company and regulatory announcements are used to explain demand mechanisms, not to independently verify global market totals.
Market Overview
The study values sales of 3-(dimethylamino)-1-propylamine, an amine intermediate produced from dimethylamine and acrylonitrile. Included uses span betaine and amine-oxide surfactants, epoxy curing agents, polyurethane catalysts, water treatment chemicals, agrochemical intermediates and lubricant additives. Finished surfactants, coatings and other downstream products are excluded from the DMAPA revenue estimate.
DMAPA is a building block for cocamidopropyl betaine and related surfactants used in shampoos, body washes and dishwashing products. Producers serving consumer brands require consistent quality and supply, so the largest application tends to support repeat orders rather than episodic equipment-style purchases.
The outlook reflects expected changes in customer adoption, procurement, technology and regulation. It should be read as a modeled scenario, not as a guarantee of sales or company performance.
Key Attributes
Attribute
Details
Base year
2025
Historical reference
2018–2025
2025 market size
USD 452.6 million
2026 estimate
USD 474.3 million
2035 market forecast
USD 731.9 million
Reported CAGR
4.92% (2025–2035)
Geographic scope
Global
Primary source
https://www.credenceresearch.com/report/dimethylaminopropylamine-market
Segmentation
By application
The study divides this category into surfactants (betaines and amine oxides); epoxy curing agents; polyurethane catalysts; water treatment chemicals; agrochemical intermediates; fuel and lubricant additives; others. Surfactants led the 2025 value mix with 61.0%. Epoxy curing agents is the fastest-growing modeled subsegment at 5.66% a year. These shares represent Credence Research model outputs, not audited supplier sales.
By end-use industry
The study divides this category into personal care and cosmetics; home care and institutional cleaning; paints, coatings and composites; water treatment; agriculture; automotive and lubricants. Personal care and cosmetics led the 2025 value mix with 44.0%. Paints, coatings and composites is the fastest-growing modeled subsegment at 5.61% a year. These shares represent Credence Research model outputs, not audited supplier sales.
Market Growth Drivers
Mild cleansing formulas sustain high-volume demand
DMAPA is a building block for cocamidopropyl betaine and related surfactants used in shampoos, body washes and dishwashing products. Producers serving consumer brands require consistent quality and supply, so the largest application tends to support repeat orders rather than episodic equipment-style purchases.
Epoxy hardeners provide a faster-growth outlet
DMAPA-based amidoamines are used in epoxy curing systems for floors, protective coatings and composite applications. Wind blade production and industrial maintenance provide additional demand. The report models epoxy curing agents as the fastest-growing application, although their value starts below surfactants.
Capacity integration shapes producer economics
The chemical route depends on dimethylamine and acrylonitrile, making feedstock access and energy costs important. Integrated producers can manage these inputs and purity requirements more directly, while regional buyers value dependable supply and local technical support.
Regional Analysis
Asia Pacific held 44.0% of modeled 2025 revenue, while Asia Pacific is expected to record the fastest regional growth at 5.88%. The allocation follows the study’s defined buyer or provider-revenue scope.
Asia Pacific
Asia Pacific represented 44.0% of modeled 2025 market value. China hosts extensive betaine and epoxy manufacturing and new intermediate capacity. Regional performance also depends on local regulation, industrial investment and purchasing conditions.
Europe
Europe represented 23.0% of modeled 2025 market value. Specialty formulations and high-purity specifications sustain demand. Regional performance also depends on local regulation, industrial investment and purchasing conditions.
North America
North America represented 21.0% of modeled 2025 market value. Personal care, coating and water treatment buyers support a mature market. Regional performance also depends on local regulation, industrial investment and purchasing conditions.
Latin America
Latin America represented 7.0% of modeled 2025 market value. Brazilian and Mexican cleaning and personal care production expands. Regional performance also depends on local regulation, industrial investment and purchasing conditions.
Middle East and Africa
Middle East and Africa represented 5.0% of modeled 2025 market value. Industrial chemicals and water treatment provide emerging outlets. Regional performance also depends on local regulation, industrial investment and purchasing conditions.
Market Challenges
Input prices and possible overcapacity
Changes in acrylonitrile and dimethylamine costs can pressure margins. New Asian capacity could also exceed near-term demand, creating price competition, especially for producers that lack integrated feedstock or differentiated purity grades.
Handling and product-purity requirements
DMAPA is a hazardous industrial intermediate requiring careful handling. Residual amines in downstream betaines can create sensitization concerns, so cosmetics customers increasingly emphasize analytical control, specifications and supplier qualification.
Future Outlook
Asia Pacific should remain the main production and demand center, with surfactants anchoring volume and epoxy applications contributing above-average growth. Supplier positioning will depend on feedstock integration, reliable logistics, high-purity grades and the pace at which new capacity is absorbed.
Competitive Landscape
BASF and Eastman Chemical are identified as integrated DMAPA producers, while Zhangjiagang Feixiang Chemical and Zhejiang Xinhua Chemical participate in Chinese production. Huntsman is relevant to downstream amine chemistry. Solvay, Evonik and Kao are better described as converters or customers for DMAPA-based surfactants rather than direct merchant DMAPA producers. No credible company-specific DMAPA revenue ranking is available.
Key Players
BASF; Eastman Chemical; Zhangjiagang Feixiang Chemical; Zhejiang Xinhua Chemical; Huntsman (downstream derivatives); Solvay (surfactants); Evonik (surfactants); Kao (surfactants)
Recent Developments
Oct. 16, 2025: BASF said the July start-up of expanded DMAPA production in Nanjing nearly doubled the site’s annual capacity and raised BASF’s global DMAPA capacity by more than 20% to approximately 85,000 metric tons.July 2025: As part of the same Nanjing project, BASF expanded polyetheramine capacity by about 25%. This is a related amine-chain investment, not an additional DMAPA plant.
Report Coverage
The study provides market estimates for 2025 and 2035, a 2026 interim estimate, analysis of the defined product and service scope, segment and geographic revenue shares, demand drivers, technology changes, competitive roles, constraints and recent dated developments. The reported CAGR and regional shares are based on Credence Research’s market model. Company announcements are contextual evidence and should not be interpreted as independent verification of the forecast.
Read the complete report and request a sample: https://www.credenceresearch.com/report/dimethylaminopropylamine-market
Related Reports
https://www.credenceresearch.com/report/apac-infectious-enteritis-treatment-market
https://www.credenceresearch.com/report/australia-digital-therapeutics-market
https://www.credenceresearch.com/report/australia-corporate-education-and-upskilling-market
https://www.credenceresearch.com/report/prescription-drugs-market
https://www.credenceresearch.com/report/orthopedic-devices-market
https://www.credenceresearch.com/report/parkinsons-disease-therapeutics-market
https://www.credenceresearch.com/report/plasma-derived-therapy-market
https://www.credenceresearch.com/report/over-the-counter-drugs-market
https://www.credenceresearch.com/report/orphan-drugs-market
https://www.credenceresearch.com/report/pediatric-drugs-market
https://www.credenceresearch.com/report/pain-management-drugs-market
https://www.credenceresearch.com/report/osteoporosis-drugs-market
https://www.credenceresearch.com/report/patient-monitoring-devices-market
https://www.credenceresearch.com/report/australia-drive-by-wire-market
https://www.credenceresearch.com/report/australia-cold-chain-and-refrigerated-transport-market
https://www.credenceresearch.com/report/australia-critical-illness-insurance-market
https://www.credenceresearch.com/report/australia-eco-friendly-labels-market
https://www.credenceresearch.com/report/apac-healthcare-digital-twins-market
https://www.credenceresearch.com/report/australia-driveline-components-market
About Us
Credence Research Inc. is a global market intelligence and consulting firm founded in 2015. It provides quantitative market research, competitive intelligence and strategic advisory services to businesses, investors and other organizations. Its research draws on primary and secondary information, industry interviews and structured market models.
The firm analyzes market size, growth drivers, segmentation, regional opportunities, supply chains and competitive positioning across industrial, technology, energy, health care and consumer markets. Its studies help clients evaluate strategic and investment decisions with documented assumptions and industry context.
Contact Us
Credence Research Inc.
Tower C-1105, S 25, Akash Tower
Vishal Nagar, Pimple Nilakh, Haveli, Pune 411027, India
USA: +1-888-600-6441
sales@credenceresearch.com
www.credenceresearch.com
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/dimethylaminopropylamine-market-to-reach-usd-731-9-million-by-2035-on-surfactant-and-epoxy-demand-credence-research-finds-302918151.html
Technology
Misty Ventures and Aplicata Technologies Announce Strategic Partnership to Pursue Canadian Defence Opportunities
Published
23 minutes agoon
October 23, 2026By
Together, Aplicata and Misty Ventures will leverage their respective expertise, networks, and resources to support the commercialization of innovative technologies and help bring impactful solutions to government and public-sector markets.
SASKATOON, SK, Oct. 23, 2026 /PRNewswire-PRWeb/ — Misty Ventures, the economic development arm of Mistawasis Nêhiyawak, and Aplicata Technologies, a trusted leader in high-performance computing platforms for mission-critical defence applications, today announced they have signed a Memorandum of Understanding to explore a strategic partnership focused on pursuing and strengthening Canadian defence market opportunities.
Aplicata and Misty Ventures have agreed to form a Saskatchewan-based joint venture to develop and commercialize electronic warfare (EW), signals intelligence (SIGINT) and intelligence, surveillance and reconnaissance (ISR) technologies for Canadian defence.
The joint venture will deliver solutions across uncrewed aerial vehicles, aircraft, ground vehicles and naval vessels, providing the Canadian Armed Forces with a decisive operational advantage through advanced, mission-critical technology. It brings together Aplicata’s engineering, manufacturing and market expertise with Misty Ventures’ business development experience and its access to skilled talent and defence markets.
A guiding principle of the partnership is to build upon the strong business acumen, entrepreneurial capacity, and strategic vision of Mistawasis Nêhiyawak and its affiliated Indigenous communities. Through this partnership, Mistawasis Nêhiyawak seeks to leverage these strengths to contribute meaningfully to Canada’s defence priorities, supporting the development of sovereign capabilities, domestic innovation, and resilient Canadian supply chains. In addition to technology licensing, Aplicata intends to support the partnership through advanced knowledge and skills development, enabling Mistawasis Nêhiyawak to further expand its participation in Canada’s defence and security ecosystem and create lasting economic opportunity.
“This partnership reflects our commitment to building long-term, sustainable economic opportunities for Mistawasis Nêhiyawak and our broader community,” said Robert Daniels, Chief Executive Officer of Misty Ventures. “By combining our experience and market reach with Aplicata’s proven technology and market expertise, we believe we can create a defence sector business that delivers real value for Canada while creating meaningful opportunities for our people.”
“Aplicata brings a long history of innovation in advanced technologies for defence,” said Mohammad Darwish, Chief Executive Officer of Aplicata Technologies. “Partnering with Misty Ventures allows us to bring our capabilities to the Canadian defence market in a way that also creates lasting economic benefit for Mistawasis Nêhiyawak. We’re excited about the opportunity to build something meaningful together.”
About Misty Ventures
Since 2015, Misty Ventures has been the economic development entity of Mistawasis Nêhiyawak, growing through strategic partnerships across Saskatchewan’s construction, mining, oil and gas, and renewable energy sectors. Misty Ventures continues to pursue investments and collaborations aligned with its vision, mission, and values.
About Aplicata Technologies
Aplicata is a trusted leader in high-performance computing platforms for mission-critical defence applications. We create innovative solutions engineered for performance and reliability, delivering results our customers can depend on. Rooted in a culture of collaboration and driven by a shared sense of purpose, we serve government and commercial organizations alike, pushing the boundaries of technology to enable new possibilities.
Media Contact
Media Relations, Aplicata Technologies, 1 (844) 250-6300, media@aplicata.com, www.aplicata.com
View original content to download multimedia:https://www.prweb.com/releases/misty-ventures-and-aplicata-technologies-announce-strategic-partnership-to-pursue-canadian-defence-opportunities-302917752.html
SOURCE Aplicata Technologies
Amid Rising Costs and Surgical Disruptions in ASCs, NorthStar Anesthesia Strengthens Focus on ASC Partnerships
Dimethylaminopropylamine Market to Reach USD 731.9 Million by 2035 on Surfactant and Epoxy Demand, Credence Research Finds
Misty Ventures and Aplicata Technologies Announce Strategic Partnership to Pursue Canadian Defence Opportunities
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Nullmax and Renesas Forge Strategic Partnership to Deliver Competitive ADAS Solutions for the Global Market
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology5 days agoGMIF2026: AI Inference Powers the “Token Factory” and Drives System-Level Rethinking of Memory & Storage
-
Technology4 days agoInstaMall Launches Same-Day Fashion Delivery Experience, Bringing 80+ Brands to Shoppers’ Doors in Miami
-
Technology5 days agoHISTOINDEX AND A*STAR PARTNER TO ADVANCE EARLY-STAGE DEVELOPMENT OF PIPELINE THERAPIES FOR FIBROTIC DISEASES
-
Coin Market4 days agoWorld Liberty’s USD1 stablecoin sheds $400M in market cap in two weeks
-
Technology4 days agoTruecaller announces preliminary numbers for the third quarter 2026
-
Technology4 days agoSALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
-
Technology4 days agoTrend Micro Announces Up to ¥10 Billion toward Cyber Resilience Initiative to Strengthen Security for Japanese Organizations in the AI Era
-
Technology4 days agoTreasuries Rallied as Tech Slid, and the Crowded Bet Against Bonds Felt It
